iShares 20+ Year Treasury Bond ETF (TLT)

TLT (NASDAQ:Financial Services) ETF
$131.50
pos +0.00
+0.00%
Today's Range: 130.93 - 133.13 | TLT Avg Daily Volume: 7,951,800
Last Update: 02/12/16 - 4:00 PM EST
Volume: 0
YTD Performance: 10.90%
Open: $0.00
Previous Close: $133.72
52 Week Range: $114.88 - $135.25
Oustanding Shares: 70,400,000
Market Cap: 9,051,328,000
6-Month Chart
TheStreet Ratings Grade for TLT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
TLT Sector Avg. S&P 500
0.00 0.00 26.86
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.91% 1.19% 14.26%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for TLT:
EBITDA 0.00B
Revenue 0.00B
Average Earnings Estimates

Earnings Estimates data is not available for TLT.

Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Doug Kass

 | Feb 12, 2016 | 6:13 PM EST
As I wrote in my opener, "At a Good Turn, You Will Not Want to Buy," I chronicled gems from legendary technical analyst Wally Deemer and expressed the view that bottoms are rarely accompanied by optimism and buying -- though I am sure the storytellers in the business media likely already will have forgotten their Cassandra-like warnings of yesterday. We closed right on my Fair Market Value calculation of 1864! We closed nearly 60 handles from yesterday's lows/test. I consider today a successful test of the 1812 capitulation low of yesterday and 3 ½ weeks ago. Today's bounce showed how many were offsides and essentially immobilized by the recent declines. Many were clearly short equities and/or crude, and today's up move demonstrated how conservatively positioned the longs are. The contrary worked this week. Does that mean we go straight up?  Obviously not. As I posted, I thought it prudent to scale back my large long exposure to between small and medium in size in front of the weekend. Frankly, I want to enjoy myself and not worry about large positions. My long "Trade of the Week," Citigroup (C), at $37.70 provided no profits but it could have been worse; it closed the week down 15 cents after some drama!  My short "Trade of the Week," iShares 20+ Year Treasury Bond ETF (TLT), was a big win of $4 in about 24 hours. I closed it and my long ProShares UltraShort 20+ Year Treasury (TBT) out.  The U.S. dollar strengthened. Crude was the standout asset class, up by $2.94 to $29.15. Gold gave back $8.60 Agricultural commodities flatlined, with wheat, corn, sugar, soybeans and oats unchanged. Lumber was up $2.10. Treasuries were nine to 10 basis points higher at the longer end  and the yield curve began to steepen from its flatness. Municipals got hit and so did closedend municipal bond funds. High yield was quite strong, maybe the largest gains in weeks. iShares iBoxx $ High Yield Corporate Bond ETF (HYG) was up $1.17 and SPDR Barclays High Yield Bond ETF (JNK) was up 47 cents. Blackstone/GSO Strategic Credit Fund (BGB) disappointed and was flat; I added to an already large holding. Jamie Dimon set the positive tone for banks this morning and so did the Deutsche Bank (DB) bond tender as well as the improvement in crude oil, and boy did the sector respond, with gains of 6% to 8%, albeit from depressed levels. Citigroup rose $2.50, JPMorgan Chase (JPM) was up $4.40 for its best day in five years, and Wells Fargo (WFC) and Comerica (CMA) also rose. I purchased depressed and controversial DB to add to my long list of bank longs. Brokerages shined, with 3% to 5% gains; see Dan Loeb on Morgan Stanley (MS) below. Life insurance stocks reversed yesterday's losses. I covered long-time life insurance shorts and purchased calls after 40% gains in only a few months. Lincoln National (LNC) and MetLife (MET) remain on my Best Ideas List because I plan to short strength. They're oversold for now, as was the market. I added to Hartford Financial Services Group (HIG) and Allstate (ALL) longs.  Retail was stronger despite some downgrades for Best Buy (BBY) and Bed, Bath and Beyond (BBBY). The stocks are dirt cheap. I continue to hold Macy's (M) -- my favorite -- BBY and BBBY. Remodelers Home Depot (HD) and Lowe's (LOW) had dead-cat bounces. Media, though higher, disappointed in its bounce-back. I remain short with small positions in Comcast (CMCSA) and Disney (DIS). Autos were higher. I covered General Motors (GM) today, but it is still on my Best Ideas List as I am a short-seller on 10% strength. Biotech was up 3%, with Valeant Pharmaceuticals (VRX) and Allergan (AGN) performing better.  My 12-stock biotech basket did well. Large caps Celgene (CELG) and Gilead Sciences (GILD) were $2 to $3 higher. Speculative Acadia Pharmaceuticals (ACAD), Portola Pharmaceuticals (PTLA) and Sage Therapeutics (SAGE) -- now up 10% from yesterday -- were stronger. (T)FANG was conspicuously weak, with negligible gains. Tesla (TSLA) was down on the day. The words in my opener rang true: "The market's former leaders (biotech, Internet, health care and consumer discretionary stocks) all seem to be in an initial leg down, but look like they're oversold and could have a weak bounce, with a test to come later. That could represent an important intermediate-term leadership change." Remember, leadership changes are typically not market-friendly.  Let's watch (T)FANG closely in the days ahead. NOSH members were all higher, but not materially so. CRABBY was happy with C, Radian Group (RDN), ALL and Alleghany (Y) faring well. Dan Loeb's Third Point just filed with 3 million shares of MS. He also increased his position in Dow Chemical (DOW). I sold two-thirds of my SPDR S&P 500 ETF (SPY) long rental and half of my iShares Russell 2000 (IWM) at good prices and for profits. This, coupled with some short covers and additional buys (including ALL, BGB and HIG), moved me from a large to between small and medium in
By

Doug Kass

 | Feb 12, 2016 | 12:34 PM EST
I've closed out my "Short Trade of the Week" -- a short of the iShares 20+ Year Treasury Bond ETF (TLT).
By

Doug Kass

 | Feb 12, 2016 | 10:55 AM EST
Our "Short Trade of the Week" -- shorting the iShares 20+ Year Treasury Bond ETF (TLT) -- is gathering momentum to the downside.
By

Doug Kass

 | Feb 12, 2016 | 9:41 AM EST
Peter Boockvar parses today's January U.S. retail-sales data, which looks like it should help my "Short Trade of the Week" -- a short of the Shares 20+ Year Treasury Bond ETF (TLT):
By

Doug Kass

 | Feb 12, 2016 | 9:02 AM EST
Financials and small-caps have broken down, but look oversold. Personally, I'm buying banks and the small-cap iShares Russell 2000 ETF (IWM). The market's former leaders (biotech, Internet, health-care and consumer-discretionary stocks) all seem to be in an initial leg down, but look like they're oversold and could have a weak bounce, with a test to come later. That could represent an important intermediate-term leadership change. A weaker U.S. dollar and a deep-oversold condition have helped most commodity-related stocks and sectors. They've had good rallies and could have a bit of a retracement, but probably a successful test. We're seeing classic signs of a flight to safety. These include higher Treasury and gold prices, a run from U.S. and European bank stocks, a continued widening in junk-bond spreads, a tentative Federal Reserve and fears of an "Ah Ha Moment" for central banks.  An emerging crisis or a final capitulation are the big issues to look out for. I expect the latter, so I'm adding to my net exposure. My "Short Trade of the Week" this week has been to short the iShares 20+ Year Treasury Bond ETF (TLT) and buy the ProShares UltraShort 20+ Year Treasury (TBT). All told, I think it's entirely possible that we get another selling climax, although we're already well into an intermediate-oversold condition. So, I favor the notion that the S&P 500 has made (or will make) a successful test of 1,812. The Bottom Line "Disasters have a way of not happening." -- Byron Wien I currently prefer the contrary view (buy) to the consensus view (sell). I also like second-level thinking rather than the orthodoxy and generally accepted fear factors permeating the markets right now. It rarely pays to be fearful when so many around you are fearful, too. That's why I've expanded my net long exposure into the market's recent weakness. To paraphrase Wally Deemer: No one wants to buy right now, so a good turn might be at hand. To me, the market's current downturn looks like it's getting extreme enough to increase the chance that a mean reversion higher isn't far away. Something's due to change -- and next week might be crucial to resolving it.
By

Bob Byrne

 | Feb 12, 2016 | 9:00 AM EST

And I would rather be prepared for them.

By

Bob Byrne

 | Feb 12, 2016 | 7:00 AM EST

Lots of opportunities Thursday, but they were largely inconsequential.

By

Doug Kass

 | Feb 11, 2016 | 4:40 PM EST
1812 support from three weeks ago held, for now. QQQs (Nasdaq) over Ss (S&P)and Rs (Russell). An extreme in sentiment is developing, as is fear/panic. As a reflection, gold rallied by $55 at ounce to $1250. Silver was up a nickel The U.S. dollar continued to experience strength. Crude oil fell below $26 and was saved by a possible supply cut. The commodity closed at $26.80, down 65 cents on the day.  Natural gas was down a nickel. Bond ripped in premarket trading. The 10-year U.S. note yield fell to 1.53% and closed at 1.63%, for a change of eight basis points. The 30-year U.S. bond closed with a yield of 2.485%, down by only four basis points in yield. The yield curve continues to flatten, serving as a headwind to banks and life insurance companies. Lincoln National (LNC) was down by nearly $4 a share.  I shorted more Berkshire Hathaway (BRK.B). As a bank trader said to me today, "For Lent I am giving up hope." Municipals were well-bid but closed-end municipal bond funds dipped small. High yield continued junky. iShares iBoxx $ High Yield Corporate Bond ETF (HYG) was down 52 cents and SPDR Barclays High Yield Bond ETF (JNK) was down 24 cents. Blackstone/GSO Strategic Credit Fund (BGB) slipped by a penny. Agricultural commodities: wheat down three cents, corn up a penny, soybeans up 11 cents. Lumber was down $3.20. Retail was broadly lower. Remodelers continue to lag after a period of superior performance. Biotech was lower, but iShares Nasdaq Biotechnology (IBB) finished well off the morning lows. Allergan (AGN), Celgene (CELG) and Valeant Pharmaceuticals (VRX) got hurt.  Energy stocks for the second day in a row rallied despite lower crude prices. Exxon Mobil (XOM) was up 60 cents and Schlumberger (SLB) was up $1.45. Old tech showed some life, with Intel (INTC), Cisco (CSCO) and Microsoft (MSFT) in the green, but IBM (IBM) continued to make new lows, down $2.50. Consumer staples weakened -- Procter & Gamble (PG) lost $1.65 and Kimberly-Clark (KMB) was down $3.60. Serial underperformers Radian Group (RDN) and Potash (POT) were higher on the day. (T)FANG did well absolutely and relatively with all components but Netflix (NFLX) higher. NOSH was all about O'Reilly Automotive (ORLY), which I highlighted in a post, and it tacked on $5 from that point. The other components were lower. CRABBY was mixed, but Citigroup (C) weighed the acronym down. I created a small basket of conservative -- Gilead Sciences (GILD) and CELG, for example -- and speculative biotech names rather than just buying IBB. Some of the spec names, such as Sage Therapeutics (SAGE) and Otonomy (OTIC), had nice turnarounds from my early-morning cost basis. I stopped myself out of my iShares Russell 2000 (IWM) long, but went back in at about the same price. I added again to C and Bank of America (BAC). My short "Trade of the Week" was shorting iShares 20+ Year Treasury Bond (TLT) at $135.60. TLT closed $2 lower than my cost basis. Rev's technical insights
By

Doug Kass

 | Feb 11, 2016 | 1:13 PM EST
Break in!
By

Mark Sebastian

 | Feb 11, 2016 | 1:00 PM EST

Things could get wild in the currency market. FXE is primed for more movement.

All; I've received a few questions about the subject of my column for this weekend about t...

Judge Smails embarrassed me into writing it!

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.